Rethinking Health Technology Assessment: Evolvi...

By João L. Carapinha

October 24, 2025

Health technology assessment plays a pivotal role in resource-constrained healthcare systems. How can organizations like NICE, ICER, and Canada's Drug Agency better incorporate novel value elements into economic evaluations? They can do so by adop...
Datroway TNBC Therapy: Transforming First-Line Treatment for Metastatic Tripl...
Pfizer Trump Drug Prices: A Landmark Deal for Affordable Medications
Biosimilars Market Trends 2025: Understanding Erosion and Growth
Strengthening the U.S. Pharmaceutical Supply Chain: Establishing a Strategic ...
Urgent Care Effectiveness: Exploring Canadian Centre Models and Health System...
Dutch Pharmacoeconomic Redesign: Streamlined Structure and Enhanced Transpare...
National Bulk Purchasing Strategy: Enhancing Drug Affordability and Access in...
The Value of Self-Care in Public Health: Insights and Implications for Europe
Canada Launches Consultation for Essential Prescription Drugs List
PCV20 Reimbursement Guidelines: Analysis of Dutch Advisory Council Recommenda...
Future-Proofing Hospitals: Singapore’s Blueprint for Smarter Healthcare
Pfizer Conference Insights: Analyzing Bourla’s Strategic Vision Amid Po...